
LGCL Valuation
Lucas GC Ltd
- Overview
- Forecast
- Valuation
- Earnings
LGCL Relative Valuation
LGCL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LGCL is overvalued; if below, it's undervalued.
Historical Valuation
Lucas GC Ltd (LGCL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Lucas GC Ltd (LGCL) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:0.50
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Lucas GC Ltd. (LGCL) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Lucas GC Ltd. (LGCL) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Lucas GC Ltd. (LGCL) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Lucas GC Ltd. (LGCL) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Lucas GC Ltd. (LGCL) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Lucas GC Ltd (LGCL) has a current Price-to-Book (P/B) ratio of 1.08. Compared to its 3-year average P/B ratio of 2.89 , the current P/B ratio is approximately -62.76% higher. Relative to its 5-year average P/B ratio of 2.89, the current P/B ratio is about -62.76% higher. Lucas GC Ltd (LGCL) has a Forward Free Cash Flow (FCF) yield of approximately -6.15%. Compared to its 3-year average FCF yield of -2.26%, the current FCF yield is approximately 172.24% lower. Relative to its 5-year average FCF yield of -2.26% , the current FCF yield is about 172.24% lower.
1.08
P/B
Median3y
2.89
Median5y
2.89
-6.15
FCF Yield
Median3y
-2.26
Median5y
-2.26
Competitors Valuation Multiple
The average P/S ratio for LGCL's competitors is 0.88, providing a benchmark for relative valuation. Lucas GC Ltd Corp (LGCL) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LGCL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of LGCL in the past 1 year is driven by Unknown.
People Also Watch

BRNS
Barinthus Biotherapeutics PLC
1.120
USD
-5.09%

ESHA
ESH Acquisition Corp
11.170
USD
-0.09%

RAPT
RAPT Therapeutics Inc
11.380
USD
-0.70%

ARBK
Argo Blockchain PLC
0.268
USD
-4.61%

INTS
Intensity Therapeutics Inc
0.282
USD
-3.09%

OM
Outset Medical Inc
13.910
USD
-0.07%

VTVT
vTv Therapeutics Inc
15.140
USD
-3.26%

PXS
Pyxis Tankers Inc
2.790
USD
+2.39%

DMYY
DMY Squared Technology Group Inc
12.667
USD
+2.62%
FAQ

Is Lucas GC Ltd (LGCL) currently overvalued or undervalued?
Lucas GC Ltd (LGCL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Lucas GC Ltd (LGCL) is between to according to relative valuation methord.

What is Lucas GC Ltd (LGCL) fair value?

How does LGCL's valuation metrics compare to the industry average?

What is the current P/B ratio for Lucas GC Ltd (LGCL) as of Sep 01 2025?

What is the current FCF Yield for Lucas GC Ltd (LGCL) as of Sep 01 2025?

What is the current Forward P/E ratio for Lucas GC Ltd (LGCL) as of Sep 01 2025?
